Malabsorption News

Healio Gastroenterology presents the following report on the top stories from UEG Week 2021.

Critically ill patients who required mechanical ventilation and received the probiotic Lactobacillus rhamnosus GG were as likely to develop ventilator-associated pneumonia as those who received placebo, a randomized clinical trial showed.

The British Society of Gastroenterology published guidelines for the management of iron deficiency anemia among an adult population.

Recent research has supported the theory of a connection between the gut and brain.

In this video exclusive, Alice Bast and Jessica Edwards George, PhD, discussed a study assessed how brain fog and other neurocognitive symptoms impact patients with celiac disease.

Healio Gastroenterology presents the following reports on recent news in COVID-19.

Transglutaminase 2 inhibitor ZED1227 decreased intestinal mucosal injury among patients with celiac disease, according to research published in The New England Journal of Medicine.

For patients with COVID-19, at 3- and 6-months, malnutrition was the most persistent gastrointestinal sequalae, according to a study published in Clinical Gastroenterology and Hepatology.

Novome Biotechnologies announced the beginning of its phase 1 trial evaluating NOV-001, a once-daily Genetically Engineered Microbial Medicine for the treatment of enteric hyperoxaluria.

In this video exclusive, Vikki Petersen, DC, CCN, CFMP, from the Root Cause Medical Clinic offers insights into Celiac disease and the importance of healing the gut.